000 01186 a2200301 4500
005 20250516165038.0
264 0 _c20150402
008 201504s 0 0 eng d
022 _a1488-2434
024 7 _a10.1503/jpn.130009
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aComai, Stefano
245 0 0 _aUnveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology.
_h[electronic resource]
260 _bJournal of psychiatry & neuroscience : JPN
_cJan 2014
300 _a6-21 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aAnxiety Disorders
_xdrug therapy
650 0 4 _aBrain
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMental Disorders
_xdrug therapy
650 0 4 _aPsychopharmacology
650 0 4 _aReceptor, Melatonin, MT2
_xgenetics
650 0 4 _aSleep Wake Disorders
_xdrug therapy
700 1 _aGobbi, Gabriella
773 0 _tJournal of psychiatry & neuroscience : JPN
_gvol. 39
_gno. 1
_gp. 6-21
856 4 0 _uhttps://doi.org/10.1503/jpn.130009
_zAvailable from publisher's website
999 _c23029279
_d23029279